International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 3 May-June 2024 Submit your research before last 3 days of June to publish your research paper in the issue of May-June.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 3
May-June 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Company Risk of Selected Pharmaceutical Companies in India During the Post-liberalisation Era: An Empirical Assessment

Author(s) Rupa Yadav
Country India
Abstract An overall improvement in health standards contributes to the economic growth of a nation. A healthy population plays a vital role in fostering a strong economy, making investments in healthcare a top priority for most countries worldwide. India plays a significant role in the global healthcare sector, particularly in the pharmaceutical industry. The Indian Pharmaceutical Industry has experienced rapid growth, with a yearly growth rate of 9.4 percent. Since Globalisation, the Indian pharmaceutical industry has undergone a remarkable transformation on the economic front, leading to the noticeable changes in the company risk patterns. As a result, Indian pharmaceutical companies have had to readjust their strategies to manage their company risks. While some companies have successfully adapted to the new environment by implementing appropriate measures, others have struggled to do so. In the present paper an attempt has been made to analyse the company risk of 15 selected Indian Pharmaceutical Companies during the period 2004-05 to 2021-22.
Keywords Key Words: Pharmaceutical Sector, Company risk, Globalisation.
Field Business Administration
Published In Volume 5, Issue 4, July-August 2023
Published On 2023-07-04
Cite This Company Risk of Selected Pharmaceutical Companies in India During the Post-liberalisation Era: An Empirical Assessment - Rupa Yadav - IJFMR Volume 5, Issue 4, July-August 2023. DOI 10.36948/ijfmr.2023.v05i04.4199
DOI https://doi.org/10.36948/ijfmr.2023.v05i04.4199
Short DOI https://doi.org/gsfxpf
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 3 Cover Page Vol 6 Isu 2 Cover Page Vol 6 Isu 1

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com